Search alternatives:
increase decrease » increased release (Expand Search), increased crash (Expand Search)
point decrease » point increase (Expand Search)
main decrease » gain decreased (Expand Search), mean decrease (Expand Search), small decrease (Expand Search)
Showing 901 - 920 results of 13,894 for search '(( significant increase decrease ) OR ( significant ((main decrease) OR (point decrease)) ))', query time: 0.71s Refine Results
  1. 901
    The change of disease burden of CRD by categories in Fujian, 1990-2021.

    The change of disease burden of CRD by categories in Fujian, 1990-2021. by Yanrong Yin (14292683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 902
    The proportion of attributable risk factors of DALYs of CRD in Fujian, 1990-2021.

    The proportion of attributable risk factors of DALYs of CRD in Fujian, 1990-2021. by Yanrong Yin (14292683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 903
    The change of attribute risk factors of DALYs in CRD in Fujian, 1990-2021.

    The change of attribute risk factors of DALYs in CRD in Fujian, 1990-2021. by Yanrong Yin (14292683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 904
    The change of disease burden of CRD in different region, 1990-2021.

    The change of disease burden of CRD in different region, 1990-2021. by Yanrong Yin (14292683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 905
    Cohesion characteristics and statistical significance analysis of different ingredients across IDDSI levels<sup>b'*'</sup>.

    Cohesion characteristics and statistical significance analysis of different ingredients across IDDSI levels<sup>b'*'</sup>. by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 906
    Adhesion characteristics and statistical significance analysis of different ingredients across IDDSI levels<sup>b'*'</sup>.

    Adhesion characteristics and statistical significance analysis of different ingredients across IDDSI levels<sup>b'*'</sup>. by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 907
    Hardness characteristics and statistical significance analysis of different ingredients across IDDSI levels<sup>b'*'</sup>.

    Hardness characteristics and statistical significance analysis of different ingredients across IDDSI levels<sup>b'*'</sup>. by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 908
    The changing trends of the main differential metabolites in the WKY, SHR and Model groups.

    The changing trends of the main differential metabolites in the WKY, SHR and Model groups. by Xiao Zhang (152326)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 909
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 910
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 911
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 912
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 913
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 914
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 915
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 916
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 917
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 918
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 919
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 920
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: